Pregnancy and Assisted Reproduction Techniques in Men and Women after Cancer Treatment

Placenta

Volumn 29, Issue SUPPL.2, 2008, Pages 152-159

  Gurgan, T ^a   Salman, C ^a   Demirol, A ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Infertility and IVF Center   (Turkey)

Author keywords

Assisted reproductive technology; Cancer treatment; Pregnancy

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ESTRADIOL; ETOPOSIDE; FLUOROURACIL; GESTAGEN; GONADORELIN AGONIST; GOSERELIN; HORMONE RECEPTOR; MELPHALAN; METHOTREXATE; PACLITAXEL; PLATINUM DERIVATIVE; PROCARBAZINE; TAMOXIFEN; TRIPTORELIN;

ABDOMINAL HYSTERECTOMY; ADJUVANT THERAPY; AGE; AMENORRHEA; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVOR; CANCER THERAPY; CERVICECTOMY; CHEMOTHERAPY; CRYOPRESERVATION; CYSTECTOMY; DRUG DOSE; EARLY MENOPAUSE; EMBRYONIC STEM CELL; ESTRADIOL BLOOD LEVEL; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GAMETE; GERM CELL TUMOR; GYNECOLOGIC CANCER; HODGKIN DISEASE; HUMAN; HYSTERECTOMY; INFERTILITY THERAPY; IONIZING RADIATION; LYMPH NODE DISSECTION; MALE FERTILITY; MALE INFERTILITY; MENSTRUATION DISORDER; NONHUMAN; OOCYTE; OOCYTE MATURATION; ORCHIECTOMY; OVARY CANCER; OVARY DISEASE; OVARY FUNCTION; OVARY INSUFFICIENCY; OVARY TOXICITY; PREGNANCY; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIATION SHIELD; SALPINGOOOPHORECTOMY; SPERM; SPERM PRESERVATION; SPERMATOGENESIS; TESTIS; TESTIS CANCER; UTERINE CERVIX CANCER; UTERUS CANCER; UTERUS SURGERY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYTOPROTECTION; FEMALE; FERTILITY; GENITAL NEOPLASMS, FEMALE; HUMANS; INFERTILITY, FEMALE; INFERTILITY, MALE; MALE; NEOPLASMS; OVARY; PREGNANCY; PREGNANCY RATE; RADIOTHERAPY; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 51549090367     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.07.007     Document Type: Article

References (82)

1. Müller J. Impact of cancer therapy on the reproductive axis. Horm Res 59 Suppl. 1 (2003) 12-20
2. Blatt J. Pregnancy outcome in long-term survivors of childhood cancer. Med Pediatr Oncol 33 (1999) 29-33
3. Arnon J., Meirow D., Lewis-Roness H., and Ornoy A. Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum Reprod Update 7 (2001) 394-403
4. Maltaris T., Koelbl H., Seufert R., Kiesewetter F., Beckmann M.W., Mueller A., et al. Gonadal damage and options for fertility preservation in female and male cancer survivors. Asian J Androl 8 (2006) 515-533
5. Lo Presti A., Ruvolo G., Gancitano R.A., and Cittadini E. Ovarian function following radiation and chemotherapy for cancer. Eur J Obstet Gynecol Reprod Biol 113 Suppl. 1 (2004) S33-S40
6. Meirow D., and Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 7 (2001) 535-543
7. Meirow D. Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers. Leuk Lymphoma 33 (1999) 65-76
8. Oktem O., and Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer 110 (2007) 2222-2229
9. Bines J., Oleske D.M., and Cobleigh M.A. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14 (1996) 1718-1729
10. Howell S., and Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am 27 (1998) 927-943
11. Zanetta G., Bonazzi C., Cantù M., Binidagger S., Locatelli A., Bratina G., et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol 19 (2001) 1015-1020
12. Reyno L.M., Levine M.N., Skingley P., Arnold A., and Abu Zahra H. Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancer. Eur J Cancer 29 (1992) 21-23
13. Boumpas D.T., Austin III H.A., Vaughan E.M., Yarboro C.H., Klippel J.H., and Balow J.E. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119 (1993) 366-369
14. Clayton P.E., Shalet S.M., Price D.A., and Jones P.H. Ovarian function following chemotherapy for childhood brain tumours. Med Pediatr Oncol 17 (1989) 92-96
15. Distler W., Kuhreke H., Jurgens H., and Graf M. Puberty and ovarian function following cytostatic therapy in childhood. Geburtshilfe Frauenheilkd 46 (1986) 237-241
16. Fisher B., and Cheung A.Y. Delayed effect of radiation therapy with or without chemotherapy on ovarian function in women with Hodgkin's disease. Acta Radiol Oncol 23 (1984) 43-48
17. Brumenfeld Z., and Haim N. Prevention of gonadal damage during cytotoxic therapy. Ann Med 29 (1997) 199-206
18. Lee C.J., Park H.H., Do B.R., Yoon Y., and Kim J.K. Natural and radiation-induced degeneration of primordial and primary follicles in mouse ovary. Anim Reprod Sci 59 (2000) 109-117
19. Wallace W.H., Thomson A.B., Saran F., and Kelsey T.W. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 62 (2005) 738-744
20. Hermann T. Radiation reactions in the gonad: importance in patient counselling. Strahlenther Onkol 173 (1997) 493
21. Thibaud E., Rodriguez-Macias K., Trivin C., Espérou H., Michon J., and Brauner R. Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant 21 (1998) 287-290
22. Hamre M.R., Robison L.L., Nesbit M.E., Sather H.N., Meadows A.T., Ortega J.A., et al. Effects of radiation on ovarian function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. J Clin Oncol 5 (1987) 1759-1765
23. Stillman R.J., Schinfeld J.S., Schiff I., Gelber R.D., Greenberger J., Larson M., et al. Ovarian failure in long-term survivors of childhood malignancy. Am J Obstet Gynecol 139 (1981) 62-66
24. Simon B., Lee S.J., Partridge A.H., and Runowicz C.D. Preserving fertility after cancer. CA Cancer J Clin 55 (2005) 211-228
25. Agarwal A., and Said T.M. Implications of systemic malignancies on human fertility. Reprod Biomed Online 9 (2004) 673-679
26. Shabbir M., and Morgan R.J. Testicular cancer. J R Soc Health 124 (2004) 217-218
27. Paduch D.A. Testicular cancer and male infertility. Curr Opin Urol 16 (2006) 419-427
28. Petersen P.M., Giwercman A., Skakkebaek N.E., and Rørth M. Gonadal function in men with testicular cancer. Semin Oncol 25 (1998) 224-233
29. Centola G.M., Keller J.W., Henzler M., and Rubin P. Effect of low dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl 15 (1994) 608-613
30. Socié G., Salooja N., Cohen A., Rovelli A., Carreras E., Locasciulli A., et al. Late Effects Working Party of the European Study Group for Blood and Marrow Transplantation. Nonmalignant late effects after allogeneic stem cell transplantation. Blood 101 (2003) 3373-3385
31. Howell S.J., and Shalet S.M. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 34 (2005) 12-17
32. Martin R.H., Hildebrand K., Yamamoto J., Rademaker A., Barnes M., Douglas G., et al. An increased frequency of human sperm chromosomal abnormalities after radiotherapy. Mutat Res 174 (1986) 219-225
33. Brougham M.F., Kelnar C.J., Sharpe R.M., and Wallace H.B. Male fertility following childhood cancer: current concepts and future therapies. Asian J Androl 5 (2003) 325-337
34. Thomson A.B., Campbell A.J., Irvine D.C., Anderson R.A., Kelnar C.J., and Wallace W.H. Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: a case-control study. Lancet 360 (2002) 361-367
35. Yarali H., Demirol A., Bukulmez O., Coskun F., and Gurgan T. Laparoscopic high lateral transposition of both ovaries before pelvic irradiation. J Am Assoc Gynecol Laparosc 7 (2000) 237-239
36. Blumenfeld Z., Avivi I., Eckman A., Epelbaum R., Rowe J.M., and Dann E.J. Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma. Fertil Steril 89 (2008) 166-173
37. Huser M., Crha I., Ventruba P., Hudecek R., Zakova J., Smardova L., et al. Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients. Hum Reprod 23 (2008) 863-868
38. Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril 83 (2005) 1622-1628
39. Donnez J., Martinez-Madrid B., Jadoul P., Van Langendonckt A., Demylle D., and Dolmans M.M. Ovarian tissue cryopreservation and transplantation: a review. Hum Reprod Update 12 (2006) 519-535
40. Lornage J., and Salle B. Ovarian and oocyte cryopreservation. Curr Opin Obstet Gynecol 19 (2007) 390-394
41. Chian R.C., Gilbert L., Huang J.Y., Demirtas E., Holzer H., Benjamin A., et al. Live birth after vitrification of in vitro matured human oocytes. Fertil Steril (2008) doi:10.1016/j.fertnstert.2007.11.088
42. Huang J.Y., Tulandi T., Holzer H., Tan S.L., and Chian R.C. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril 89 (2008) 567-572
43. Donnez J., Dolmans M.M., Demylle D., Jadoul P., Pirard C., Squifflet J., et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364 (2004) 1405-1410
44. Meirow D., Levron J., Eldar-Geva T., Hardan I., Fridman E., Zalel Y., et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 353 (2005) 318-321
45. Sanger W.G., Olson J.H., and Sherman J.K. Semen cryobanking for men with cancer-criteria change. Fertil Steril 58 (1992) 1024-1027
46. Shin D., Lo K.C., and Lipshultz L.I. Treatment options for the infertile male with cancer. J Natl Cancer Inst Monogr 34 (2005) 48-50
47. Kuczyński W., Dhont M., Grygoruk C., Grochowski D., Wołczyński S., and Szamatowicz M. The outcome of intracytoplasmic injection of fresh and cryopreserved ejaculated spermatozoa-a prospective randomized study. Hum Reprod 16 (2001) 2109-2113
48. Carson S.A., Gentry W.L., Smith A.L., and Buster J.E. Feasibility of semen collection and cryopreservation during chemotherapy. Hum Reprod 6 (1991) 992-994
49. Orwig K.E., and Schlatt S. Cryopreservation and transplantation of spermatogonia and testicular tissue for preservation of male fertility. J Natl Cancer Inst Monogr 34 (2005) 51-56
50. Brinster R.L., and Zimmermann J.W. Spermatogenesis following male germ-cell transplantation. Proc Natl Acad Sci USA 91 (1994) 11298-11302
51. Keros V., Hultenby K., Borgström B., Fridström M., Jahnukainen K., and Hovatta O. Methods of cryopreservation of testicular tissue with viable spermatogonia in pre-pubertal boys undergoing gonadotoxic cancer treatment. Hum Reprod 22 (2007) 1384-1395
52. Tesarik J., Bahceci M., Ozcan C., Greco E., and Mendoza C. Restoration of fertility by in-vitro spermatogenesis. Lancet 353 (1999) 555-556
53. Daley G.Q. Gametes from embryonic stem cells: a cup half empty or half full?. Science 316 (2007) 409-410
54. Sonoda Y., Abu-Rustum N.R., Gemignani M.L., Chi D.S., Brown C.L., Poynor E.A., et al. A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible?. Gynecol Oncol 95 (2004) 534-538
55. Abu-Rustum N.R., Sonoda Y., Black D., Levine D.A., Chi D.S., and Barakat R.R. Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: technique and review of the literature. Gynecol Oncol 103 (2006) 807-813
56. Roy M., and Plante M. Pregnancies after radical vaginal trachelectomy for early-stage cervical cancer. Am J Obstet Gynecol 179 6 Pt 1 (1998) 1491-1496
57. Boss E.A., van Golde R.J., Beerendonk C.C., and Massuger L.F. Pregnancy after radical trachelectomy: a real option?. Gynecol Oncol 99 3 Suppl. 1 (2005) S152-S156
58. Plante M., Renaud M.C., François H., and Roy M. Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature. Gynecol Oncol 94 (2004) 614-623
59. Evans-Metcalf E.R., Brooks S.E., Reale F.R., and Baker S.P. Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 91 (1998) 349-354
60. Yang Y.C., Wu C.C., Chen C.P., Chang C.L., and Wang K.L. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer. Gynecol Oncol 99 (2005) 287-293
61. Gotlieb W.H., Beiner M.E., Shalmon B., Korach Y., Segal Y., Zmira N., et al. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstet Gynecol 102 (2003) 718-725
62. Demirol A., Bahce M., Ayhan A., and Gurgan T. Pregnancy following intracytoplasmic sperm injection and preimplantation genetic diagnosis after the conservative management of endometrial cancer. Reprod Biomed Online 10 (2005) 770-773
63. Gurgan T., Bozdag G., Demirol A., and Ayhan A. Preserving fertility before assisted reproduction in women with endometrial carcinoma: case report and literature review. Reprod Biomed Online 15 (2007) 561-565
64. Gershenson D.M. Fertility-sparing surgery for malignancies in women. J Natl Cancer Inst Monogr 34 (2005) 43-47
65. Gershenson D.M. Management of ovarian germ cell tumors. J Clin Oncol 25 (2007) 2938-2943
66. Schneider D.T., Calaminus G., Wessalowski R., Pathmanathan R., Selle B., Sternschulte W., et al. Ovarian sex cord-stromal tumors in children and adolescents. J Clin Oncol 21 (2003) 2357-2363
67. Barakat R.R. Borderline tumors of the ovary. Obstet Gynecol Clin North Am 21 (1994) 93-105
68. Bjorge T., Engeland A., Hansen S., and Trope C.G. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993. Int J Cancer 71 (1997) 780-786
69. Swanton A., Bankhead C.R., and Kehoe S. Pregnancy rates after conservative treatment for borderline ovarian tumours: a systematic review. Eur J Obstet Gynecol Reprod Biol 135 (2007) 3-7
70. Zanetta G., Chiari S., Rota S., Bratina G., Maneo A., Torri V., et al. Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecol 104 (1997) 1030-1035
71. Schilder J.M., Thompson A.M., DePriest P.D., Ueland F.R., Cibull M.L., Kryscio R.J., et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol 87 (2002) 1-7
72. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., et al. American Cancer Society. Cancer statistics. CA Cancer J Clin 2004 54 (2004) 8-29
73. McCarthy N.J. Care of the breast cancer survivor: increased survival rates present a new set of challenges. Postgrad Med 116 (2004) 39-40
74. Gadducci A., Cosio S., and Genazzani A.R. Ovarian function and childbearing issues in breast cancer survivors. Gynecol Endocrinol 23 (2007) 625-631
75. Recchia F., Saggio G., Amiconi G., Di Blasio A., Cesta A., Candeloro G., and Rea S. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer 106 (2006) 514-523
76. Del Mastro L., Catzeddu T., Boni L., Bell C., Sertoli M.R., Bighin C., et al. Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann Oncol 17 (2006) 74-78
77. Cuzick J., Ambroisine L., Davidson N., Jakesz R., Kaufmann M., Regan M., et al. LHRH-agonists in Early Breast Cancer Overview group Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials. Lancet 369 (2007) 1711-1723
78. Oktay K., Hourvitz A., Sahin G., Oktem O., Safro B., Cil A., et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 91 (2006) 3885-3890
79. Oktay K., Buyuk E., Libertella N., Akar M., and Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23 (2005) 4347-4353
80. Gemignani M.L., and Petrek J.A. Pregnancy after breast cancer. Cancer Control 6 (1999) 272-276
81. Kesic V. Fertility after the treatment of gynecologic tumors. Recent Results Cancer Res 178 (2008) 79-95
82. Meirow D., Epstein M., Lewis H., Nugent D., and Gosden R.G. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod 16 (2001) 632-637